Crossmark

Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial

Published Online: 2021-08-10

Published Print: 2021-12

Authors

Di Santo, Pietro

Mathew, Rebecca

Jung, Richard G.

Simard, Trevor

Skanes, Stephanie

Mao, Brennan

Ramirez, F. Daniel

Marbach, Jeffrey A.

Abdel-Razek, Omar

Motazedian, Pouya

Parlow, Simon

Boczar, Kevin E.

D’Egidio, Gianni

Hawken, Steven

Bernick, Jordan

Wells, George A.

Dick, Alexander

So, Derek Y.

Glover, Christopher

Russo, Juan J.

McGuinty, Caroline

Hibbert, Benjamin http://orcid.org/0000-0003-0906-1363
,
Funding

Funding for this research was provided by:

academic health sciences centres of ontario
License Information

Text and Data Mining valid from 2021-08-10

Version of Record valid from 2021-08-10
More Information

Article History

Received: 29 October 2020

Accepted: 19 February 2021

First Online: 10 August 2021

Declarations

:

: Ethics approval was obtained from the Ottawa Health Science Network Research Ethics Board and the study was conducted in accordance with the Helsinki Declaration. Written informed consent was obtained from all participants or their substitute decision maker.

: Not applicable.

: None to declare.

Document is current